SCHEMBL6709083

SCHEMBL6709083

Cc1n[nH]c(C)c1C(=O)Nc1ccc2c(c1)OCO2

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.60
HTT P42858 1/20 0.59
RAB9A P51151 12/20 0.58
MAPT P10636 8/20 0.58
NPC1 O15118 12/20 0.57
SMN1; SMN2 Q16637 9/20 0.57
TP53 P04637 6/20 0.56
HSP90AA1 P07900 1/20 0.56
HSP90AB1 P08238 1/20 0.56
PKM P14618 3/20 0.56
NFKB1 P19838 1/20 0.56
NFKB2 Q00653 1/20 0.56
RELA Q04206 1/20 0.56
HPGD P15428 2/20 0.55
AHR P35869 1/20 0.54
KDM4E B2RXH2 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
MAPK1 P28482 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6709452 0.85 RAB9A (0.55) ALDH1A1HTTRAB9AMAPTNPC1
SCHEMBL6707854 0.85 ALDH1A1 (0.44) ALDH1A1HTTRAB9AMAPTNPC1
SCHEMBL6709079 0.81 RAB9A (0.59) ALDH1A1HTTRAB9AMAPTNPC1
SCHEMBL6707951 0.79 ALDH1A1 (0.74) ALDH1A1HTTRAB9AMAPTNPC1
SCHEMBL6707874 0.78 NPC1 (0.62) ALDH1A1HTTRAB9AMAPTNPC1
SCHEMBL4631791 0.74 AURKA (0.51) ALDH1A1RAB9AMAPTNPC1SMN1; SMN2
SCHEMBL6710604 0.73 NPC1 (0.63) ALDH1A1RAB9AMAPTNPC1SMN1; SMN2
SCHEMBL27179668 0.73 RAB9A (0.90) ALDH1A1RAB9AMAPTNPC1SMN1; SMN2
SCHEMBL4647917 0.73 NPC1 (0.77) ALDH1A1HTTRAB9AMAPTNPC1
SCHEMBL5460655 0.73 RAB9A (0.69) ALDH1A1HTTRAB9AMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040102489-A1 Heteroarylcarboxamide compounds active against protein tyrosine kinase related disorders SUGEN, INC. 2004-05-27 US disclosed
US-20020065283-A1 Heteroarylcarboxamide compounds active against protein tyrosine kinase related disorders MCMAHON GERALD (US) 2002-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020065283-A1 Heteroarylcarboxamide compounds active against protein tyrosine kinase related disorders ABL1, ERBB2, PRKDC ALDH1A1 3956/4885HTT 1790/4885RAB9A 1132/4885
US-20040102489-A1 Heteroarylcarboxamide compounds active against protein tyrosine kinase related disorders ABL1, ERBB2, PRKDC ALDH1A1 3956/4885HTT 1790/4885RAB9A 1132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.